Global

Europe Overview: Portugal, Hungary hunker down against Europe’s virus surge

Mon, 2020-11-09 09:39 — mike kraft

Portugal, Hungary hunker down against Europe's virus surge LISBON, Portugal (AP) — Portugal and Hungary on Monday became the latest European countries to impose curfews against the resurgent tide of coronavirus infections and deaths lashing the continent... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Europe Overview: Portugal, Hungary hunker down against Europe’s virus surge
Log in or register to post comments

Pfizer says early data signals COVID-19 vaccine is effective

Mon, 2020-11-09 08:56 — mike kraft

Pfizer says early data signals COVID-19 vaccine is effective Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use... AP NEWS

Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer says early data signals COVID-19 vaccine is effective
Log in or register to post comments

An Explanation for Some Covid-19 Deaths May Not Be Holding Up

Sun, 2020-11-08 19:44 — mike kraft

Medical researchers are raising significant doubts about whether an agent of the human immune system causes some coronavirus patients to end up in the hospital with injured lungs and other organs, struggling to breathe. What remains is a continuing mystery about what causes certain people to die from Covid-19, and how best to prevent that.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about An Explanation for Some Covid-19 Deaths May Not Be Holding Up
Log in or register to post comments

Global coronavirus cases exceed 50 million after 30-day spike

Sun, 2020-11-08 12:29 — mike kraft

Global coronavirus cases exceed 50 million after 30-day spike Global coronavirus infections exceeded 50 million on Sunday, according to a Reuters tally, with a second wave of the virus in the past 30 days accounting for a quarter of the total. Anurag Maan, Shaina Ahluwalia, Kavya B U.S.

(Reuters) - Global coronavirus infections exceeded 50 million on Sunday, according to a Reuters tally, with a second wave of the virus in the past 30 days accounting for a quarter of the total.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Global coronavirus cases exceed 50 million after 30-day spike
Log in or register to post comments

ADDITIONAL REPORTING: How a Coronavirus Mutation in Minks Could Wreak Havoc on Vaccine Development

Sat, 2020-11-07 16:52 — mike kraft

How a Coronavirus Mutation in Minks Could Wreak Havoc on Vaccine Development A new strain of SARS-CoV-2 in Danish minks is raising fears among public health experts. Matt Miller Slate Magazine

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about ADDITIONAL REPORTING: How a Coronavirus Mutation in Minks Could Wreak Havoc on Vaccine Development
Log in or register to post comments

The time is now to develop a testing strategy for asymptomatic Covid-19 cases, CDC director says

Sat, 2020-11-07 11:05 — mike kraft

The time is now to develop a testing strategy for asymptomatic Covid-19 cases, CDC director says As the US recorded its five highest days of coronavirus cases, Centers for Disease Control and Prevention Director Dr. Robert Redfield said this is the perfect time to develop a strategy to better detect asymptomatic cases. Amir Vera and Christina Maxouris, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about The time is now to develop a testing strategy for asymptomatic Covid-19 cases, CDC director says
Log in or register to post comments

Books? Hairdressers? Europeans split on lockdown essentials

Sat, 2020-11-07 10:46 — mike kraft

Books? Hairdressers? Europeans split on lockdown essentials HALLE, Belgium (AP) — In times when a pandemic unleashes death and poverty, the concept of what is essential to keep society functioning in a lockdown is gripping Europe. Beyond the obvious... AP NEWS

HALLE, Belgium (AP) — In times when a pandemic unleashes death and poverty, the concept of what is essential to keep society functioning in a lockdown is gripping Europe.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Books? Hairdressers? Europeans split on lockdown essentials
Log in or register to post comments

UPDATE: U.S. daily coronavirus cases exceed 129,000, third day over 100,000

Sat, 2020-11-07 10:14 — mike kraft

U.S. daily coronavirus cases exceed 129,000, third day over 100,000 U.S. coronavirus infections surged by at least 129,606 on Friday, according to a Reuters tally, the third consecutive daily rise of more than 100,000 cases as a third wave of COVID-19 sweeps the United States. Anurag Maan U.S.

Reuters) - U.S. coronavirus infections surged by at least 129,606 on Friday, according to a Reuters tally, the third consecutive daily rise of more than 100,000 cases as a third wave of COVID-19 sweeps the United States.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UPDATE: U.S. daily coronavirus cases exceed 129,000, third day over 100,000
Log in or register to post comments

AstraZeneca says COVID-19 vaccine could arrive in January of next year

Fri, 2020-11-06 17:17 — mike kraft

A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.

The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.

AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.

Country / Region Tags:

General Topic Tags: